Ravi Misra
Stock Analyst at Truist Financial
(0.47)
# 4,322
Out of 4,673 analysts
45
Total ratings
35%
Success rate
-10.7%
Average return
Main Sectors:
Stocks Rated by Ravi Misra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORGO Organogenesis Holdings | Maintained: Hold | $2 | $1.80 | +11.11% | 3 | Aug 11, 2026 | |
| TFX Teleflex | Reiterated: Hold | $143 → $150 | $138.83 | +8.05% | 3 | Aug 10, 2026 | |
| KIDS OrthoPediatrics | Reiterated: Hold | $20 → $22 | $25.65 | -14.23% | 3 | Aug 5, 2026 | |
| IART Integra LifeSciences Holdings | Maintained: Hold | $14 → $19 | $16.74 | +13.50% | 4 | Jul 16, 2026 | |
| ALGN Align Technology | Rated: Hold | n/a | $162.55 | n/a | 4 | Dec 13, 2021 | |
| DXCM DexCom | Rated: Hold | n/a | $92.34 | n/a | 2 | Dec 13, 2021 | |
| PODD Insulet | Rated: Hold | n/a | $148.16 | n/a | 3 | Dec 13, 2021 | |
| TNDM Tandem Diabetes Care | Rated: Hold | n/a | $22.32 | n/a | 2 | Dec 13, 2021 | |
| GKOS Glaukos | Rated: Hold | n/a | $184.89 | n/a | 2 | Dec 13, 2021 | |
| TDOC Teladoc Health | Rated: Hold | n/a | $6.39 | n/a | 7 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $62.36 | n/a | 5 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8599 | n/a | 2 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.90 | n/a | 4 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $283 | $378.81 | n/a | 1 | Apr 19, 2017 |
Organogenesis Holdings
Aug 11, 2026
Maintained: Hold
Price Target: $2
Current: $1.80
Upside: +11.11%
Teleflex
Aug 10, 2026
Reiterated: Hold
Price Target: $143 → $150
Current: $138.83
Upside: +8.05%
OrthoPediatrics
Aug 5, 2026
Reiterated: Hold
Price Target: $20 → $22
Current: $25.65
Upside: -14.23%
Integra LifeSciences Holdings
Jul 16, 2026
Maintained: Hold
Price Target: $14 → $19
Current: $16.74
Upside: +13.50%
Align Technology
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $162.55
Upside: n/a
DexCom
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $92.34
Upside: n/a
Insulet
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $148.16
Upside: n/a
Tandem Diabetes Care
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $22.32
Upside: n/a
Glaukos
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $184.89
Upside: n/a
Teladoc Health
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $6.39
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $62.36
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $0.8599
Upside: n/a
Dec 13, 2021
Rated: Hold
Price Target: n/a
Current: $11.90
Upside: n/a
Apr 19, 2017
Reiterated: Buy
Price Target: $283
Current: $378.81
Upside: n/a